MedPath

Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy

Not Applicable
Conditions
According to the diagnostic criteria for mood (affective) disorders:ICD-10
Registration Number
JPRN-UMIN000029134
Lead Sponsor
Department of Pychiatry, Kitasato University East hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Otherwise excluded from study participants. (1) if the person or from the Novotel was discontinued participation in research proposal (2) in the PreTac fluid and Gerad Z-101BA until now or further if any allergic symptoms

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Static impedance (measured with 6 microampere) at placing electrodes on the patient skin and dynamic impedance (measured with 0.9 ampere) during administrating electric current to the brain.
Secondary Outcome Measures
NameTimeMethod
umber of times spent with saimapad and Postictal Suppression Index (decrease in value immediately after the attack, completed average amplitude of 3 seconds between viewed in percent as reduced the average amplitude of the maximum amplitude of the seizure during 3 seconds, which one of the indicators of the quality of the attack)
© Copyright 2025. All Rights Reserved by MedPath